M C52 (Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg)

Pill imprint M C52 has been identified as Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa (orally disintegrating)

Imprint:

M C52

Strength:

25 mg / 100 mg

Color:

Blue

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-5052

Inactive Ingredients:

aspartame
crospovidone
mannitol
microcrystalline cellulose
silicon dioxide
sodium stearyl fumarate
sorbitol
FD&C Blue No. 1

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.